Searched for
SEZ DRUG MANUFACTURERS
Cadila Healthcare's US arm receives FDA nod to market Pimavanserin capsuleThe approval by the US Food & Drug Administration for the generic Pimavanserin capsules is for the strength of 34 mg, Cadila Healthcare sai...
Zydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drugDrug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used...
Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...
Zydus Cadila gets USFDA nod for generic drugAlbuterol is a bronchodilator which helps open up the airways in the lungs to make it easier to breathe. The medicine is used to treat and ...
Zydus Cadila gets tentative USFDA nod for generic drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...
Zydus Cadila gets USFDA nod to market generic cancer drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version o...
Zydus Cadila gets USFDA nod for breast cancer drugThe company said it will manufacture the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad.
Dr Reddy's Labs jumps 6% as Andhra formulation unit receives EIRThe domestic drug maker have been facing regulatory hurdles of late.
Zydus Cadila gets EIR from USFDA for Pharma SEZ plant at AhmedabadThe company's "formulations manufacturing facility at Pharma SEZ, Ahmedabad has received an EIR from the USFDA signifying the successful cl...
USFDA finds company's SEZ Indore unit acceptable: Ipca LabsThis will enable the company to commercialise oral solid dosage formulations in the US market from this manufacturing facility.
- Ranbaxy begins Atorvastation exports to US
Ranbaxy Laboratories has commenced exports of Atorvastation Calcium tablets to the US market from its Mohali SEZ manufacturing facility.
- Serum Institute to go solo with Pune biotech SEZ
India’s largest vaccine maker Serum Institute plans to go ahead with its proposed biotech SEZ project in Pune on its own, after several glo...
- Torrent Group to expand pharma facility, set up SEZ
It’s all about expansion at Torrent Group, which has interests in pharma and power.
- Dishman to invest Rs 500 cr in two SEZs
Drug maker Dishman Pharmaceuticals on Thursday said it will invest Rs 500 crore in two special economic zones and has completed acquisition...
- Dishman Pharma rises 10% on expansion plans
Shares of Dishman Pharmaceuticals & Chemicals surged nearly 10 per cent after it announced plans to invest Rs 5 billion in two SEZs and ent...
- Ranbaxy seeks to sell drugs from new Mohali plant in US
Ranbaxy Laboratories has filed for US Food and Drug Administration's (USFDA) approval to sell medicines from its upcoming manufacturing uni...
- Tokyo's Eisai to invest Rs 500 cr in Vizag SEZ
Tokyo-based pharma major Eisai has zoomed on India to set up a new Rs 500 crore manufacturing and R&D centre.